|
⚲
|
| Keyboard |
| Dhingra Kapil | |
|---|---|
| Firm | |
| Address | Lasker Biomedical Research Building 3960 Broadway, Suite 540 New York, NY 10032 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Exosome Diagnostics Inc | 021-213510 | Director | 27.1 M of 40.0 M |
||
| Exosome Diagnostics Inc | 021-183134 | Director | 7.0 M of 8.5 M |
||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Replimune Group Inc REPL
Stock Option (right to buy) · derivative
|
2025-12-09 | Option exercise | 3,169 | $0.00 | |
|
Replimune Group Inc REPL
Common Stock
|
2025-12-09 | Sell | 3,169 | $10.40 | 32,958 |
|
Replimune Group Inc REPL
Common Stock
|
2025-12-09 | Option exercise | 3,169 | $1.75 | 5,546 |
|
Lava Therapeutics NV LVTX
Common Shares
|
2025-11-13 | Disposed to issuer | 30,000 | ||
|
Lava Therapeutics NV LVTX
Share Options (Right to Buy) · derivative
|
2025-11-13 | Disposed to issuer | 33,390 | $0.00 | |
|
CARGO Therapeutics Inc CRGX
Stock Option (Right to Buy) · derivative
|
2025-08-19 | Disposed to issuer | 25,000 | ||
|
CARGO Therapeutics Inc CRGX
Stock Option (Right to Buy) · derivative
|
2025-06-18 | Grant | 25,000 | $0.00 | |
|
Black Diamond Therapeutics Inc BDTX
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 30,550 | $0.00 | |
|
Replimune Group Inc REPL
Stock Option (right to buy) · derivative
|
2025-04-01 | Grant | 32,000 | $0.00 | |
|
Lava Therapeutics NV LVTX
Common Shares (Right to Buy) · derivative
|
2025-02-13 | Grant | 33,390 | $0.00 | |
|
Black Diamond Therapeutics Inc BDTX
Stock Option (Right to Buy) · derivative
|
2024-06-06 | Grant | 30,550 | $0.00 | |
|
CARGO Therapeutics Inc CRGX
Stock Option (Right to Buy) · derivative
|
2024-06-04 | Grant | 11,871 | $0.00 | |
|
CARGO Therapeutics Inc CRGX
Stock Option (Right to Buy) · derivative
|
2024-04-15 | Grant | 49,265 | $0.00 | |
|
Replimune Group Inc REPL
Stock Option (right to buy) · derivative
|
2024-04-01 | Grant | 32,000 | $0.00 | |
|
Black Diamond Therapeutics Inc BDTX
Stock Option (Right to Buy) · derivative
|
2023-05-16 | Grant | 16,500 | $0.00 | |
|
Replimune Group Inc REPL
Stock Option (right to buy) · derivative
|
2023-04-01 | Grant | 25,200 | $0.00 | |
|
Black Diamond Therapeutics Inc BDTX
Stock Option (Right to Buy) · derivative
|
2022-06-10 | Grant | 15,000 | $0.00 | |
|
Replimune Group Inc REPL
Stock Option (right to buy) · derivative
|
2022-04-01 | Grant | 16,500 | $0.00 | |
|
Black Diamond Therapeutics Inc BDTX
Stock Option (Right to Buy) · derivative
|
2021-06-18 | Grant | 15,000 | $0.00 | |
|
Five Prime Therapeutics Inc FPRX
Stock Option (right to buy) · derivative
|
2021-04-16 | Disposed to issuer | 25,000 | ||
| showing 20 of 40 most recent transactions | |||||